What is Opus Genetics's investing cash flow?

Opus Genetics (IRD) reported investing cash flow of $0 in Q1 2026.

What is the long-term trend for Opus Genetics's investing cash flow?

Over 4 years (2021 to 2025), Opus Genetics's investing cash flow has grown at a -100.0% compound annual growth rate (CAGR), from -$100K to $0.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Opus Genetics IRD Investing Cash Flow

Investing Cash Flow at other companies

AbbVieABBV

-$574M+21.9%

MeiraGTx Holdings plcMGTX

-$2.26M-32.0%

4D Molecular TherapeuticsFDMT

$68.89M+116%

Opko HealthOPK

-$1.8M-104%

Kodiak Sciences IncKOD

-$942K-249%

Regeneron PharmaceuticalsREGN

-$428.9M-166%

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's investing cash flow?: Opus Genetics (IRD) reported investing cash flow of $0 in Q1 2026.
What is the long-term trend for Opus Genetics's investing cash flow?: Over 4 years (2021 to 2025), Opus Genetics's investing cash flow has grown at a -100.0% compound annual growth rate (CAGR), from -$100K to $0.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.